Work

Polatuzumab Vedotin and Glofitamab for Relapsed/Refractory Diffuse Large B‐Cell Lymphoma in the Compassionate Use Program in Italy

Year: 2025

Type: article

Abstract: NA

Source: Hematological Oncology

DOI: 10.1002/hon.70161

Authors: Pier Luigi Zinzani, Giulia Dell’Omo, Letizia Fusco, Ilaria Peduto, Carlotta Galeone, Federica Cavallo, Giuseppe Gritti

Institutions: Istituto di Ematologia di Bologna, University of Bologna, Roche (Italy), University of Milano-Bicocca, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, University of Turin, Ospedale Papa Giovanni XXIII

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,650

OpenAlex ID: W4417312177

FWCI:

Cites: 4

Cited by:

Related to: